# TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE
> **ANDA211572** · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2024-08-05
## Drug
- **FDA Application Number:** ANDA211572
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE
- **Generic name:** POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE
- **Active ingredients:** POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE
- **Dosage form:** SOLUTION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** SOMERSET THERAPS LLC
- **Manufacturer:** Somerset Therapeutics, LLC
- **First approval:** 2024-08-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211572)
---
*AI Analytics · CC0 1.0*